Abbvie (ABBV) PT Lowered to $80 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond lowered the price target on Abbvie (NYSE: ABBV) to $80.00 (from $90.00) while maintaining a Neutral rating.
Piper Jaffray analyst Christopher Raymond lowered the price target on Abbvie (NYSE: ABBV) to $80.00 (from $90.00) while maintaining a Neutral rating.